Mito now offers a coronary artery calcium scan without a referral. Here’s what it shows, what it costs and what a zero doesn't promise.

AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the ...

Six of ten patients in a small trial improved by two or more steps on a severity scale after one treatment, though the data ...

Annovis Bio is using an AI tool to speed up its FDA filing for buntanetap, a drug aimed at Alzheimer’s and Parkinson’s. The paperwork is a part of drug development that almost never makes headlines. A ...

Aged beagle data hint at lower biological age and preliminary muscle changes with SIRT6c treatment, although key readouts ...

As peptides surge in popularity, better evidence and cleaner supply chains could help the field grow without leaving patients ...

What happens when demand for peptide therapies starts moving faster than the science, regulation and clinical infrastructure surrounding them? Phil Newman sits down with Dr. Fady Hannah-Shmouni and ...

Two Lilly candidates posted fresh data in type 2 diabetes, and how the numbers were counted matters as much as the numbers.

Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data ...

Ten innovations spanning diagnostics, AI, mobility, mitochondria and regenerative medicine have been recognized at a Hong Kong summit.